• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噻氯匹定对耻骨上前列腺切除术患者血小板功能、出血及术后血栓形成的影响。

The effect of Ticlopidine upon platelet function, haemorrhage and post-operative thrombosis in patients undergoing suprapubic prostatectomy.

作者信息

Brommer E J

出版信息

J Int Med Res. 1981;9(3):203-10. doi: 10.1177/030006058100900310.

DOI:10.1177/030006058100900310
PMID:7238995
Abstract

In order to study in its protective effect against post-operative thrombosis, Ticlopidine was administered to one out of two randomized groups of patients undergoing suprapubic prostatectomy. Bleeding time, platelet function, and haematological parameters were followed. Blood loss during operation and post-operatively were estimated, transfusions required and subjective tolerance were recorded. Among twenty-six evaluated patients receiving Ticlopidine, positive leg scans were found in four, whereas among twenty patients treated with acenocoumarol post-operatively, positive leg scans were found in seven patients. The difference is not statistically significant, thus Ticlopidine appears to offer a protection against deep venous thrombosis comparable to that of acenocoumarol. A score is introduced for comparison of the results of aggregation tests. Platelet aggregability diminished during the use of the drug, but the adhesiveness was not influenced by Ticlopidine. The bleeding time was prolonged in both groups studied. Ticlopidine did not raise per-operative blood loss and caused only slightly more haematuria post-operatively. The subjective tolerance was good.

摘要

为研究噻氯匹定对耻骨上前列腺切除术后血栓形成的保护作用,将其给予两组随机分组接受耻骨上前列腺切除术患者中的一组。对出血时间、血小板功能和血液学参数进行跟踪。估计手术期间和术后的失血量,记录所需输血情况和主观耐受性。在26例接受噻氯匹定治疗的评估患者中,4例腿部扫描呈阳性,而在20例术后接受醋硝香豆素治疗的患者中,7例腿部扫描呈阳性。差异无统计学意义,因此噻氯匹定似乎提供了与醋硝香豆素相当的预防深静脉血栓形成的保护作用。引入一个评分用于比较聚集试验结果。用药期间血小板聚集性降低,但噻氯匹定不影响血小板黏附性。研究的两组出血时间均延长。噻氯匹定未增加术中失血量,术后仅导致稍多的血尿。主观耐受性良好。

相似文献

1
The effect of Ticlopidine upon platelet function, haemorrhage and post-operative thrombosis in patients undergoing suprapubic prostatectomy.噻氯匹定对耻骨上前列腺切除术患者血小板功能、出血及术后血栓形成的影响。
J Int Med Res. 1981;9(3):203-10. doi: 10.1177/030006058100900310.
2
Prevention by ticlopidine of platelet consumption during extracorporeal circulation for heart surgery and lack of effect on operative and postoperative bleeding.噻氯匹定对心脏手术体外循环期间血小板消耗的预防作用以及对手术中和术后出血无影响。
J Cardiovasc Pharmacol. 1981 Nov-Dec;3(6):1174-83. doi: 10.1097/00005344-198111000-00003.
3
The effect of ticlopidine upon plasma fibrinogen levels in patients undergoing suprapubic prostatectomy.噻氯匹定对耻骨上前列腺切除术患者血浆纤维蛋白原水平的影响。
Thromb Res. 1993 May 15;70(4):349-54. doi: 10.1016/0049-3848(93)90108-z.
4
[Ticlopidine in heart surgery with cardiopulmonary by-pass (author's transl)].噻氯匹定在心肺转流心脏手术中的应用(作者译)
Nouv Presse Med. 1980 Nov 15;9(43):3249-51.
5
Future of oral antiplatelet therapy: four challenged hypotheses.口服抗血小板治疗的未来:四个具有挑战性的假说。
Thromb Haemost. 2009 Jun;101(6):1041-3.
6
Antiaggregatory, physiological and clinical effects of ticlopidine in subjects with peripheral atherosclerosis.噻氯匹定对周围动脉粥样硬化患者的抗聚集、生理及临床作用
Atherosclerosis. 1980 Aug;36(4):471-80. doi: 10.1016/0021-9150(80)90240-3.
7
[Use of a new platelet aggregation inhibitor, ticlopidine, in hemodialysis].[一种新型血小板聚集抑制剂噻氯匹定在血液透析中的应用]
Arch Maragliano Patol Clin. 1979;35(2):73-80.
8
A comparative cohort study on personalised antiplatelet therapy in PCI-treated patients with high on-clopidogrel platelet reactivity. Results of the ISAR-HPR registry.高氯吡格雷反应性经皮冠状动脉介入治疗患者个体化抗血小板治疗的对比队列研究。ISAR-HPR 登记研究结果。
Thromb Haemost. 2014 Aug;112(2):342-51. doi: 10.1160/TH13-10-0874. Epub 2014 Apr 10.
9
A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study.
Clin Nephrol. 1984 Mar;21(3):184-7.
10
Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).噻吩吡啶治疗患者治疗后血小板反应非常低的临床意义:POBA 研究(抗血小板药物致出血预测因子)。
JACC Cardiovasc Interv. 2013 Aug;6(8):854-63. doi: 10.1016/j.jcin.2013.04.009.

引用本文的文献

1
Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.抗血小板治疗随机试验的协作综述——I:各类患者长期抗血小板治疗预防死亡、心肌梗死和中风。抗血小板试验协作组。
BMJ. 1994 Jan 8;308(6921):81-106.
2
Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.噻氯匹定。对其药效学、药代动力学特性以及在血小板相关疾病状态下的治疗效果的综述。
Drugs. 1987 Aug;34(2):222-62. doi: 10.2165/00003495-198734020-00003.
3
Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders.
噻氯匹定。其药理学及在血小板相关疾病治疗应用的最新综述。
Drugs. 1990 Aug;40(2):238-59. doi: 10.2165/00003495-199040020-00006.